CIK 0001844417 · <br>Emerging growth company
Estrella Immunopharma, Inc.
Sign in to watch- Ticker
- ESLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 861314502
- Phone
- (510) 318-9098
- Business address
- 5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
- Former names
- TradeUP Acquisition Corp.
Securities
- ESLA Common Stock Nasdaq
- ESLAW Warrant Nasdaq
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Delisting notice · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change
- 4 Other disposition 10% owner disposed of 255,000 shares (other)
- 25-NSE Other Notification of Removal from Listing
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Unregistered share sale
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 425 Deal Prospectus/Communication re Business Combination
Page 6 of 13 · 258 filings